Koneksa Study at ATS 2018 Shows Benefits of Remote Monitoring to Increase Study Power

Today, Koneksa presented an abstract validating the use of remote measurements for patients with asthma.

The abstract, “Validating Remote FEV1 Monitoring in Moderate Asthmatics to Increase Study Power,” was presented at a Thematic Poster Session on “Asthma: Pathophysiology and Clinical Trials" at the American Thoracic Society International Conference in San Diego.

The study, done in collaboration with Regeneron Pharmaceuticals, demonstrated that even with fewer than 20 patients, clinically meaningful changes could be detected.

See the full press release here.

See the abstract here.